SCHEMBL5695960

SCHEMBL5695960

C=CCOc1ccccc1-c1ccc(S(=O)(=O)C(=C)C#N)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 7/20 0.42
HTT P42858 1/20 0.38
LIG1 P18858 1/20 0.38
USP2 O75604 1/20 0.38
GAA P10253 1/20 0.37
KMT2A Q03164 1/20 0.37
HPGD P15428 2/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
RECQL P46063 1/20 0.36
DRD2 P14416 1/20 0.36
DRD4 P21917 1/20 0.36
DRD5 P21918 1/20 0.36
DRD3 P35462 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5696006 0.87 HTT (0.36) HTTLIG1USP2GAAKMT2A
SCHEMBL5695950 0.81 DRD1 (0.38) DRD1HTTKMT2AHPGDMAPK1
SCHEMBL5696010 0.79 PTGS2 (0.38) DRD1KMT2AHPGDKDM4EALDH1A1
SCHEMBL5695952 0.77 DRD1 (0.40) DRD1HTTUSP2HPGDMAPK1
SCHEMBL9469860 0.75 SQOR (0.44) DRD1HTTLIG1GAAKMT2A
SCHEMBL6111939 0.73 GAA (0.50) DRD1HTTLIG1USP2GAA
SCHEMBL515196 0.73 ADRB2 (0.59) HTTLIG1USP2GAAKMT2A
SCHEMBL19921086 0.72 ADRB2 (0.48) DRD1HTTLIG1GAAKMT2A
SCHEMBL9431758 0.71 RXRA (0.61) HTTLIG1USP2GAAKMT2A
SCHEMBL29107282 0.70 SYK (0.54) DRD1HTTLIG1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7138108-B2 Photoprotective UV-screening compositions comprising (phenylsulfonyl) acrylonitrile-substituted silanes/siloxanes L'OREAL (FR) 2006-11-21 US claimed
EP-1371654-B1 Sunscreen compositions containing silane or siloxane derivatives of phenylsulfon acrylonitrile, phenylsulfon acrylonitrile derivatives and their use as UV filter OREAL (FR) 2006-06-14 EP claimed
US-20040037791-A1 Photoprotective UV-screening compositions comprising (phenylsulfonyl) acrylonitrile-substituted silanes/siloxanes SOCIETE L'OREAL S.A. (FR) 2004-02-26 US claimed
EP-1371654-A1 Sunscreen compositions containing silane or siloxane derivatives of phenylsulfon acrylonitrile, phenylsulfon acrylonitrile derivatives and their use as UV filter L'OREAL (FR) 2003-12-17 EP claimed
US-7138108-B2 Photoprotective UV-screening compositions comprising (phenylsulfonyl) acrylonitrile-substituted silanes/siloxanes L'OREAL (FR) 2006-11-21 US disclosed
EP-1371654-B1 Sunscreen compositions containing silane or siloxane derivatives of phenylsulfon acrylonitrile, phenylsulfon acrylonitrile derivatives and their use as UV filter OREAL (FR) 2006-06-14 EP disclosed
US-20040037791-A1 Photoprotective UV-screening compositions comprising (phenylsulfonyl) acrylonitrile-substituted silanes/siloxanes SOCIETE L'OREAL S.A. (FR) 2004-02-26 US disclosed
EP-1371654-A1 Sunscreen compositions containing silane or siloxane derivatives of phenylsulfon acrylonitrile, phenylsulfon acrylonitrile derivatives and their use as UV filter L'OREAL (FR) 2003-12-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040037791-A1 Photoprotective UV-screening compositions comprising (phenylsulfonyl) acrylonitrile-substituted silanes/siloxanes ARSA, CUTA, AHR DRD1 3980/4885HTT 501/4885LIG1 1626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.